Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood

Journal of Clinical Oncology

Volumn 12, Issue 5, 1994, Pages 916-924

  Liesner, Raina J ^a   Leiper, Alison D ^a   Hann, Ian M ^a   Chessells, Judith M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CHILD; DRUG EFFECT; FEMALE; HEARING IMPAIRMENT; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WHOLE BODY RADIATION;

EID: 0028347630     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.5.916     Document Type: Article

References (48)

1. Phillips M, Richards S, Chessells J: Acute myeloid leukaemia in childhood: The costs and benefits of intensive treatment. Br J Haematol 77:473-477, 1991
2. Creutzig U, Ritter J, Schellong G: Acute Myelogenous Leukemia in Childhood. Berlin, Germany, Springer-Verlag, 1990
3. Wells RJ, Woods WG, Lampkin BC, et al: Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: A report from the Childrens Cancer Group. J Clin Oncol 11:538-545, 1993
4. Geller R: Post-remission therapy of acute myelocytic leukemia in adults: Curability breeds controversy. Leukemia 6:915-925, 1992
5. Chessells JM: Myelodysplasia. Balliere's Clin Haematol: 4.2:459-482, 1991
6. Marcus RE, Catovsky D, Prentice HG, et al: Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML). Joint trial 1982-1985. Hamatol Bluttransfus 30:346-351, 1987
7. Stevens RF: Acute leukaemias. Ballieres Clinical Haematology: 4.2:429-458, 1991
8. Tanner JM, Whitehouse RH, Takaishi M: Standards from birth to maturity for height, weight, height velocity and weight velocity: British children. Arch Dis Child 41:613-635, 1966
9. Brook CGD: Growth Assessment in Childhood and Adolescence. Oxford, UK, Blackwell, 1982
10. Tanner JM, Whitehouse RH, Cameron et al: Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 method). London, UK, Academic, 1983
11. Tanner JM: Growth and Adolescence (ed 2). Oxford, UK, Blackwell, 1962
12. Ivarsson SA, Nilsson KO, Persson PH: Ultrasonography of the pelvic organs in prepubertal and postpubertal girls. Arch Dis Child 58:352-354, 1983
13. Stanhope R, Adams J, Jacobs HS, et al: Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism. Arch Dis Child 60:116-119, 1985
14. Salardi S, Orsini LF, Cacciari E, et al: Pelvic ultrasonography in premenarcheal girls: Relation to puberty and sex hormone concentrations. Arch Dis Child 60:120-125, 1985
15. Chantier C, Barrett TM: Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child 47:613-617, 1972
16. Henry WL, Gardin JM, Ware JH, et al: Echocardiographic measurements in normal subjects from infants to old age. Circulation 62:1054-1061, 1980
17. Franklin RCG, Wyse RKH, Graham TP et al: Normal values for non-invasive estimation of left ventricular contractile state and afterload in children. Am J Cardiol 65:505-510, 1990
18. Sanders JE, Pritchard S, Mahoney P, et al: Growth and development following marrow transplantation for leukaemia. Blood 68:1129-1135, 1986
19. Leiper AD, Stanhope R, Lau T et al: The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 67:419-426, 1987
20. Leiper AD, Stanhope R, Kitching P, et al: Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child 62:1107-1112, 1987
21. Wheeler K, Leiper A, Jannoun L, et al: Medical cost of curing acute lymphoblastic leukaemia. Br Med J 296:162-166, 1988
22. Clayton PE, Shalet SM, Morris-Jones PH, et al: Growth in children treated for acute lymphoblastic leukaemia. Lancet 1:461-463, 1988
23. Kirk JA, Raghupathy P, Stevens M, et al: Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1:190-190, 1987
24. Hann IM: CNS-directed therapy in childhood acute lymphoblastic leukaemia. Br J Haematol 82:2-5, 1992
25. Bramswig JH, Heimes U, Heiermann E, et al: The effects of different cumulative doses of chemotherapy on testicular function. Cancer 65:1298-1302, 1990
26. Li FP, Gimbrere K, Gelber RD, et al: Outcome of pregnancy in survivors of Wilms' tumor. JAMA 257:216-219, 1987
27. Bloomer WD, Hellman S: Normal tissue responses to radiation therapy. N Engl J Med 293:80-83, 1975
28. Deeg JH, Flournoy N, Sullivan KM, et al: Cataracts after total body irradiation and marrow transplantation. Int J Radiat Oncol Biol Phys 10:957-964, 1984
29. Calissendorf B, Bolme P, El Azazi M: The development of cataract in children as a late side effect of bone marrow transplantation. Bone Marrow Transplant 7:427-429, 1991
30. Sklar CA, Kim TH, Ramsay NKC: Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 73:688-694, 1982
31. Von Hoff DD, Rozencweig M, Layard M, et al: Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. Am J Med 62:200-208, 1977
32. Von Hoff DD, Layard MW, Basa P, et al: Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710-717, 1979
33. Lipschultz SE, Colan SD, Gelber RD, et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukaemia in childhood. N Engl J Med 324:808-815, 1991
34. Bachur NR, Gordon SL, Gee MV: A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38:1745-1750, 1978
35. Billingham ME, Mason JW, Bristow MR, et al: Anthracycline toxicity monitored by morphologic changes. Cancer Treat Rep 62:865-872, 1978
36. Merrill J, Greco FA, Zimbler H, et al: Adriamycin and radiation: Synergistic cardiotoxicity. Ann Intern Med 82:122-123, 1975
37. Makinen L, Makipernaa A, Rautonen J, et al: Long-term cardiac sequelae after treatment of malignant tumors with radiotherapy or cytostatics in childhood. Cancer 65:1913-1917, 1990
38. Weiss RB, Grillo-Lopez AJ, Marsoni S, et al: Amsacrine-associated cardiotoxicity: An analysis of 82 cases. J Clin Oncol 4:918-928, 1986
39. Dukart G, Posner L, Henry D, et al: Comparative toxicity of mitoxantrone vs doxorubicin. Proc Am Soc Clin Oncol 5:48, 1986 (abstr 189)
40. Steinherz LJ, Steinherz PG, Mangiacasale D, et al: Cardiac changes with cyclophosphamide. Med Pediatr Oncol 9:417-422, 1981
41. Yeung ST, Yoong C, Spink J, et al: Functional impairment in children treated with anmracyclines for cancer. Lancet 337:816-818, 1991
42. Steinherz LJ, Graham T, Hurwitz R, et al: Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 89:942-949, 1992
43. Shapira J, Gotfreid M, Lishner M, et al: Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. Cancer 65:870-873, 1990
44. Legha SS, Benjamin RS, Mackay B, et al: Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 96:133-139, 1982
45. Green MD, Speyer JL, Stacy P, et al: ICRF-187 (ICRF) prevents doxorubicin cardiotoxicity: Results of a randomised clinical trial. Proc Am Soc Clin Oncol 6:28, 1987 (abstr 104)
46. Blaise BD, Maraninchi D, Archimbaud E, et al: Allogeneic bone marrow transplantation for acute myeloid leukaemia in first remission: A randomised trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: A report from the Groupe d'Etudes de la Greffe de Moelle Osseuse. Blood 79:2578-2582, 1992
47. Ozkaynak M, Weinberg K, Kohn D, et al: Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: Incidence, risk factors, and clinical outcome. Bone Marrow Transplant 7:467-474, 1991
48. Morgan M, Dodds A, Atkinson K, et al: The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation. Br J Haematol 77:529-534, 1991